Xiaoye Li
Impact in
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 17
- Atrial Fibrillation Management and Outcomes 15
- Cardiac Arrhythmias and Treatments 6
- Acute Myocardial Infarction Research 5
-
- Aortic Disease and Treatment Approaches 13
- Co-authors
- Qing Xu (11 shared papers)Li Fan (3 shared papers)Shengyong Zhang (2 shared papers)Chong Cheng (1 shared paper)Qian Yang (1 shared paper)Fei Li (1 shared paper)Haitao Zhang (1 shared paper)Chunhu Gu (1 shared paper)
- Journals
- Frontiers in Pharmacology (7 papers)Frontiers in Cardiovascular Medicine (5 papers)International Journal of Clinical Pharmacy (3 papers)Journal of Endovascular Therapy (3 papers)Advanced Healthcare Materials (2 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Xiaoye Li
94 papers receiving 906 citations
Peers
Comparison fields: 5 of 111
- Cardiology and Cardiovascular Medicine 201
- Biomaterials 121
- Internal Medicine 27
- Pharmacology 45
- Complementary and alternative medicine 36
Countries citing papers authored by Xiaoye Li
This map shows the geographic impact of Xiaoye Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoye Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoye Li more than expected).
Fields of papers citing papers by Xiaoye Li
This network shows the impact of papers produced by Xiaoye Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoye Li. The network helps show where Xiaoye Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoye Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 139 | |
| 2 | 2005 | 36 | |
| 3 | 2022 | 32 | |
| 4 | 2022 | 32 | |
| 5 | 2020 | 31 | |
| 6 | 2010 | 28 | |
| 7 | 2024 | 26 | |
| 8 | 2023 | 26 | |
| 9 | 2017 | 24 | |
| 10 | 2010 | 23 | |
| 11 | 2017 | 23 | |
| 12 | 2018 | 18 | |
| 13 | 2021 | 17 | |
| 14 | 2019 | 16 | |
| 15 | 2022 | 16 | |
| 16 | 2020 | 15 | |
| 17 | 2020 | 15 | |
| 18 | 2024 | 14 | |
| 19 | 2021 | 14 | |
| 20 | 2024 | 13 |
About Xiaoye Li
Xiaoye Li is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Biomedical Engineering, having authored 105 papers that have together received 917 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (17 papers), Atrial Fibrillation Management and Outcomes (15 papers), Aortic Disease and Treatment Approaches (13 papers), Cardiac Arrhythmias and Treatments (6 papers), Acute Myocardial Infarction Research (5 papers), Nanoplatforms for cancer theranostics (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Animal Disease Management and Epidemiology (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (201 citations), Biomaterials (121 citations), Internal Medicine (27 citations), Pharmacology (45 citations) and Complementary and alternative medicine (36 citations). Xiaoye Li has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Qing Xu, Li Fan, Shengyong Zhang, Chong Cheng, Qian Yang, Fei Li, Haitao Zhang, Chunhu Gu, Hong Wu and Yukun Wang. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Cardiovascular Medicine, International Journal of Clinical Pharmacy, Journal of Endovascular Therapy and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.